Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Computed Tomography | Research article

Clinical and radiographic characteristics, management and short-term outcomes of patients with COVID-19 in Wenzhou, China

Authors: Liang Hong, Enling Ye, Gangqiang Sun, Xiaoyang Wang, Shengguo Zhang, Yanghe Wu, Xiangao Xie, Shichun Xia, Xudong Zheng, Ling Dong, Fujing Cai, Xixian Lou, Renguo Zhao, Yongqi Hu, Zhanwei Ruan, Jiguang Ding, Qingfeng Sun

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Coronavirus disease 2019 (COVID-19) is an emerging viral disease. Here, we report the clinical features, management, and short-term outcomes of COVID-19 patients in Wenzhou, China, an area outside Wuhan.

Methods

Patients admitted to the Infectious Diseases Department of Ruian People’s Hospital in Wenzhou, from January 21 to February 7, 2020, were recruited. Medical data on epidemiological history, demographics, clinical characteristics, laboratory tests, chest computerized tomography (CT) examination, treatment, and short-term outcomes were retrospectively reviewed. Blood biochemistry and routine tests were examined using standard methods and automatic machines. CT examination was performed several times during hospitalization as necessary.

Results

A total of 67 confirmed COVID-19 cases were diagnosed; 64 (95.4%) were common cases and three (4.5%) were severe cases. The most common symptoms at admission were fever (86.6%), cough (77.6%), productive cough (52.2%), chest distress (17.9%), and sore throat (11.9%), followed by diarrhea (7.4%), headache (7.4%), shortness of breath (6.0%), dizziness (4.5%), muscular soreness (4.5%), and running nose (4.5%). Thirty patients (47.8%) had increased C-reactive protein levels. The CT radiographs at admission showed abnormal findings in 54 (80.6%) patients. The patients were treated mainly by oxygen therapy and antiviral drugs. By March 3, 2020, all 67 patients completely recovered and had negative nucleic acid tests. The patients were discharged from the hospital and transferred to a medical observation isolation center for further observation.

Conclusion

Cases of COVID-19 in Wenzhou are milder and have a better prognosis, compared to those in Wuhan. Timely and appropriate screening, diagnosis, and treatment are the key to achieve good outcomes.
Literature
5.
go back to reference Mahase E. China coronavirus: what do we know so far? Journal. 2020. Mahase E. China coronavirus: what do we know so far? Journal. 2020.
6.
go back to reference Team TNCPERE. The Epidemiological Characteristics of an Outbreak of 2019 Novel coronavirus diseases (COVID-19) — China, 2020. China CDC Weekly 2020. Team TNCPERE. The Epidemiological Characteristics of an Outbreak of 2019 Novel coronavirus diseases (COVID-19) — China, 2020. China CDC Weekly 2020.
14.
go back to reference Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020. https://doi.org/10.1093/gerona/glaa089. Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020. https://​doi.​org/​10.​1093/​gerona/​glaa089.
17.
go back to reference Yuen K-Y, Chan P, Peiris M, Tsang D, Que T, Shortridge K, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza a H5N1 virus. Lancet. 1998;351:467–71.CrossRef Yuen K-Y, Chan P, Peiris M, Tsang D, Que T, Shortridge K, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza a H5N1 virus. Lancet. 1998;351:467–71.CrossRef
20.
go back to reference Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–3 e3.CrossRef Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158:1831–3 e3.CrossRef
22.
go back to reference Virus WCotSWHOCoCAoHIwAIA. Update on avian influenza a (H5N1) virus infection in humans. N Engl J Med. 2008;358:261–73.CrossRef Virus WCotSWHOCoCAoHIwAIA. Update on avian influenza a (H5N1) virus infection in humans. N Engl J Med. 2008;358:261–73.CrossRef
24.
go back to reference Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. Wmj. 2016;115:317–21.PubMed Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. Wmj. 2016;115:317–21.PubMed
31.
go back to reference Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020.
Metadata
Title
Clinical and radiographic characteristics, management and short-term outcomes of patients with COVID-19 in Wenzhou, China
Authors
Liang Hong
Enling Ye
Gangqiang Sun
Xiaoyang Wang
Shengguo Zhang
Yanghe Wu
Xiangao Xie
Shichun Xia
Xudong Zheng
Ling Dong
Fujing Cai
Xixian Lou
Renguo Zhao
Yongqi Hu
Zhanwei Ruan
Jiguang Ding
Qingfeng Sun
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05528-z

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine